Quantum BioPharma (STU:0K91) Net Change in Cash : €-0.45 Mil (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Quantum BioPharma Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Quantum BioPharma's Net Change in Cash for the three months ended in Sep. 2024 was €-0.17 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.45 Mil.

Quantum BioPharma Net Change in Cash Historical Data

The historical data trend for Quantum BioPharma's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum BioPharma Net Change in Cash Chart

Quantum BioPharma Annual Data

Trend

Aug15

Aug16

Aug17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-8.94

9.50

15.70

-17.26

-13.04

Quantum BioPharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Change in Cash	Get a 7-Day Free Trial															-1.66	-0.80	-1.31	1.84	-0.17

Quantum BioPharma Net Change in Cash Calculation

Quantum BioPharma's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-9.928	+	-0.248	+	-2.867	+	0
	=	-13.04

Quantum BioPharma's Net Change in Cash for the quarter that ended in Sep. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -3.118 + -3.121 + 6.071 + 0

= -0.17

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quantum BioPharma Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Quantum BioPharma's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quantum BioPharma Ltd (STU:0K91) » Definitions » Net Change in Cash

Comparable Companies

TSXV:DB TSX:CWEB TSX:MDP TSXV:ZYUS XCNQ:MMEN XCNQ:CXXI XCNQ:GRIN TSX:AVNT XCNQ:ACRG.A.U XCNQ:GDNS ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

QNTM:USA QNTM:Canada

Address

199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9

Website

https://www.fsdpharma.com

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Quantum BioPharma Headlines

No Headlines